Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-10-07
S
Suzanne L. Saccente
C. Suzanne “Carolyn” Saccente, M.D.
Also affiliated: Arkansas Children's Hospital (1997–2025); Augusta University (2001); University of Arkansas Medical Center (2004–2023); University of Alabama at Birmingham (1995)
8 h-index
24 pubs
673 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Suzanne Saccente's research focuses on the health outcomes and treatment patterns of children with sickle cell disease. Her work investigates factors influencing health care use, such as parental adverse childhood experiences, and examines the impact of evolving clinical guidelines, including race-neutral predictive equations for spirometry results. Saccente also studies neurocognitive assessments in adolescents with sickle cell disease and shifts in disease-modifying therapies during the transition from pediatric to adult care. Her publications include analyses of clinical treatment patterns and outcomes from long-term follow-up databases. Saccente has an h-index of 8 with 24 publications and 658 citations. She collaborates with researchers at the University of Arkansas for Medical Sciences and the University of Arkansas at Little Rock.
Metrics
- h-index: 8
- Publications: 24
- Citations: 673
Positions
-
University of Arkansas for Medical Sciences publications 2003–2025Pediatrics ORCID
-
C. Suzanne “Carolyn” Saccente, M.D. publications 2003–2025University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
A61-04 Bronchodilator Response in Children With Sickle Cell Disease and Its Correlation With Acute Chest Syndrome (2026)
-
Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease (2025)
-
Grandchildren of GRNDaD : Shifts in disease‐modifying therapy at the adolescent transition in sickle cell disease (2025)
-
Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease (2025)
-
Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease (2025)
-
Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease (2024)
-
Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients (2024)
-
P498: Clinical treatment patterns and outcomes of sickle cell from the Arkansas newborn screening long term follow-up database study: 2011-2023 (2024)
-
Neurosurgical intervention improves cognitive functioning in a child with sickle cell disease (2024)
-
Constipation and hemolytic uremic syndrome (2023)
-
Coronavirus disease-2019 in pediatric patients with sickle cell disease: a single institution experience (2023)
-
Pupil Size and Reactivity in Pediatric Patients with Sickle Cell Disease (2020)
-
Comparison of automated red cell exchange transfusion and simple transfusion for the treatment of children with sickle cell disease acute chest syndrome (2013)
-
Comparison of Erythrocytapheresis and Simple Transfusion for the Treatment of Children with Sickle Cell Disease Acute Chest Syndrome (2012)
-
A Single Institution Study of Chronic Erythrocytapheresis for Secondary Stroke Prevention in Children and Young Adults with Sickle Cell Disease (2012)
Collaboration Network
Top Collaborators
Robert L. Saylors
Arkansas Children's Hospital (US)
6 shared publications
- Efficacy of continuous infusion 2‐CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis
- Comparison of automated red cell exchange transfusion and simple transfusion for the treatment of children with sickle cell disease acute chest syndrome
- Long‐term survival in osteosarcoma patients following retinoblastoma using doxorubicin, cisplatin, and methotrexate
- C-Reactive Protein and Soluble IL-2Receptor Correlate with High Risk of Clinical Sepsis Among Children with Fever and Neutropenia.
- A Single Institution Study of Chronic Erythrocytapheresis for Secondary Stroke Prevention in Children and Young Adults with Sickle Cell Disease
Showing 5 of 6 shared publications
Xinyu Tang
University of Arkansas for Medical Sciences (US)
3 shared publications
- Comparison of automated red cell exchange transfusion and simple transfusion for the treatment of children with sickle cell disease acute chest syndrome
- A Single Institution Study of Chronic Erythrocytapheresis for Secondary Stroke Prevention in Children and Young Adults with Sickle Cell Disease
- Comparison of Erythrocytapheresis and Simple Transfusion for the Treatment of Children with Sickle Cell Disease Acute Chest Syndrome
Kimo C. Stine
University of Arkansas for Medical Sciences
3 shared publications
In database
- Efficacy of continuous infusion 2‐CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis
- Long‐term survival in osteosarcoma patients following retinoblastoma using doxorubicin, cisplatin, and methotrexate
- C-Reactive Protein and Soluble IL-2Receptor Correlate with High Risk of Clinical Sepsis Among Children with Fever and Neutropenia.
Joana M. Mack
Arkansas Children's Hospital
3 shared publications
In database
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
- Pupil Size and Reactivity in Pediatric Patients with Sickle Cell Disease
Shelley E. Crary
Arkansas Children's Hospital
3 shared publications
In database
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
- Pupil Size and Reactivity in Pediatric Patients with Sickle Cell Disease
- Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease
Z. Ghazala
University of Arkansas for Medical Sciences
3 shared publications
In database
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
M. Pertzborn
University of Arkansas for Medical Sciences
3 shared publications
In database
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
M. Feimster
University of Tennessee Health Science Center (US)
3 shared publications
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
Ariel Berlinski
Arkansas Children's Hospital
3 shared publications
In database
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
Sharada A. Sarnaik
Wayne State University (US)
2 shared publications
- Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure
- Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.
Gladstone Airewele
Baylor College of Medicine (US)
2 shared publications
- Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure
- Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.
Françoise Bernaudin
Hôpital Intercommunal de Créteil (FR)
2 shared publications
- Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure
- Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.
Beng Fuh
East Carolina University (US)
2 shared publications
- Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure
- Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.
Mark E. Heiny
Indiana University – Purdue University Indianapolis (US)
2 shared publications
- Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure
- Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.
Thomas H. Howard
University of Alabama at Birmingham (US)
2 shared publications
- Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure
- Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.
Similar Researchers
Based on overlapping research topics
M. Pertzborn
University of Arkansas for Medical Sciences
Child and Adolescent Health
Metabolism and Genetic Disorders
Health disparities and outcomes
A. Thatikala
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Health disparities and outcomes
Racial and Ethnic Identity Research
Praveen Kumar Ramani
University of Arkansas for Medical Sciences
Child and Adolescent Health
Metabolism and Genetic Disorders
Neurological disorders and treatments
Elizabeth A. Sellars
University of Arkansas for Medical Sciences
Child and Adolescent Health
Metabolism and Genetic Disorders
Neurological disorders and treatments
Evan D. Hicks
University of Arkansas for Medical Sciences
Child and Adolescent Health
Metabolism and Genetic Disorders
Neurological disorders and treatments
Bahaa Al-Azzam
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Health disparities and outcomes
Racial and Ethnic Identity Research